Atlas Trials

Dupilumab in Chronic Spontaneous Urticaria

Clinical trial NCT03749135 · COMPLETED

Trial details

NCT number
NCT03749135
Sponsor
Charite University, Berlin, Germany
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Spontaneous UrticariaRecurrent Angioedema
Start date
2018-11-12
Primary completion
2021-07-07
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.